In Vitro Susceptibility of Coxiella burnetii to Linezolid in Comparison with Its Susceptibilities to Quinolones, Doxycycline, and Clarithromycin

ABSTRACT The in vitro susceptibility to linezolid shown by nine Greek isolates of Coxiella burnetii derived from patients with acute Q fever was investigated. MICs of linezolid were compared with those of pefloxacin, ciprofloxacin, ofloxacin, trovafloxacin, doxycycline, and clarithromycin using the shell vial assay. MICs of linezolid and clarithromycin ranged from 2 to 4 μg/ml; those of doxycycline, trovafloxacin, and ofloxacin ranged from 1 to 2 μg/ml; those of pefloxacin ranged from 1 to 4 μg/ml; and those of ciprofloxacin ranged from 4 to 8 μg/ml. Linezolid was effective in controlling intracellular parasites in cultures of Vero cells infected by C. burnetii. No bactericidal activity by linezolid was obtained against C.burnetii at 8 μg/ml.

[1]  J. C. Maddox,et al.  Linezolid and reversible myelosuppression. , 2001, JAMA.

[2]  C. W. Ford,et al.  Linezolid, critical characteristics. , 2000, Infection.

[3]  R. Jones,et al.  Oxazolidinones: a review. , 2000, Drugs.

[4]  R. Wise,et al.  The in-vitro activity of linezolid (U-100766) and tentative breakpoints. , 1998, The Journal of antimicrobial chemotherapy.

[5]  H. Aoki,et al.  The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria , 1998, Antimicrobial Agents and Chemotherapy.

[6]  Y. Tselentis,et al.  In Vitro Susceptibility of Coxiella burnetii to Trovafloxacin in Comparison with Susceptibilities to Pefloxacin, Ciprofloxacin, Ofloxacin, Doxycycline, and Clarithromycin , 1998, Antimicrobial Agents and Chemotherapy.

[7]  A. Gikas,et al.  Q Fever in the Greek Island of Crete: Detection, Isolation, and Molecular Identification of Eight Strains of Coxiella burnetii from Clinical Samples , 1998, Journal of Clinical Microbiology.

[8]  A. Gikas,et al.  Q fever in the Greek Island of Crete: epidemiologic, clinical, and therapeutic data from 98 cases. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  W. Craig.  Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. , 1995, Diagnostic microbiology and infectious disease.

[10]  E. Rubinstein,et al.  The inhibitory effect of fluoroquinolones on Coxiella burnetii growth in in-vitro systems. , 1994, The Journal of antimicrobial chemotherapy.

[11]  F Nistal de Paz,et al.  [Q fever]. , 1994, Medicina clinica.

[12]  D. Raoult,et al.  In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin , 1993, Antimicrobial Agents and Chemotherapy.

[13]  D. Raoult,et al.  Treatment of Q fever , 1993, Antimicrobial Agents and Chemotherapy.

[14]  D. Raoult,et al.  In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay , 1993, Antimicrobial Agents and Chemotherapy.

[15]  D. Raoult,et al.  Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. , 1992, The Journal of infectious diseases.

[16]  D. Raoult,et al.  Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin , 1992, Antimicrobial Agents and Chemotherapy.

[17]  D. Raoult,et al.  Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii , 1991, Antimicrobial Agents and Chemotherapy.

[18]  D. Raoult,et al.  Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis , 1991, Antimicrobial Agents and Chemotherapy.

[19]  M. Yeaman,et al.  In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones , 1987, Antimicrobial Agents and Chemotherapy.